Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.
Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in more than 40 countries.
Industry partners and service providers
Loading…
Aclairo
USA
Loading…
Loading…

Ajinomoto Bio-Pharma Services (GeneDesign, Inc.)
Japan
Loading…

Amatsi Aquitaine (formerly Bertin Pharma)
France
Loading…
Loading…

AMG Consultants
UK
Loading…

Anacor Pharmaceuticals (now Pfizer Inc.)
USA

Analytical Services International
UK
Loading…
Loading…

Astellas Pharma Inc.
Japan

AstraZeneca
Sweden

AstraZeneca UK
United Kingdom
Loading…

Basilea Pharmaceutica AG
Switzerland
Loading…

Bayer Healthcare AG
Germany

BioDelivery Sciences International Inc.
USA
Loading…
Loading…

Biotrial
France
Loading…
Loading…

Boehringer Ingelheim
Germany
Loading…

Brazilian Biosciences National Laboratory (LNBio)
Brazil
Loading…

Cardiabase (Banook Group)
France
Loading…
Loading…

Celgene (now Bristol Myers Squibb Inc.)
USA

Centipharm
France
Loading…
Loading…

Charles River Laboratories (formerly WIL Research)
France

Chemelectiva
Italy
Loading…
Loading…

Cyprotex
USA
Loading…
Loading…

Daiichi Sankyo
Japan

Daiichi Sankyo RD Novare Co., Ltd.
Japan
Loading…

Doppel Pharma
Italy
Loading…
Loading…

Dow AgroSciences LLC
USA
Loading…

Eisai Co., Ltd.
Japan

Epichem
Australia
Loading…

Eurofarma
Brazil
Loading…

Eurofins CEREP
France
Loading…

Evonik
Germany
Loading…
Loading…

Genomics Institute of The Novartis Research Foundation (GNF)
USA
Loading…
Loading…

GlaxoSmithKline (GSK)
UK
Loading…

GlaxoSmithKline (GSK) – Spain
Spain

GVK Biosciences
India
Loading…
Loading…

Hypha Discovery Ltd
UK
Loading…
Loading…

ICON, Inc
USA
Loading…
Loading…

ImaBiotech
France
Loading…
Loading…